TCMP
BMY icon

Thrive Capital Management (Pennsylvania)’s Bristol-Myers Squibb BMY Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,307
Closed -$202K – 172
2025
Q1 		$202K Buy
+3,307
New +$193K 0.12% 111
2024
Q4 		– Sell
-4,313
Closed -$223K – 105
2024
Q3 		$223K Buy
+4,313
New +$202K 0.11% 171
2024
Q2 		– Sell
-3,888
Closed -$211K – 184
2024
Q1 		$211K Buy
+3,888
New +$198K 0.11% 115
2022
Q4 		– Sell
-3,510
Closed -$250K – 116
2022
Q3 		$250K Sell
3,510
-569
-14% -$41.3K 0.17% 94
2022
Q2 		$314K Buy
4,079
+1,069
+36% +$81.4K 0.22% 75
2022
Q1 		$220K Buy
+3,010
New +$202K 0.13% 89

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return